WHO ICTRP trial
A phase-III clinical trial to study the effects of vitamin D3 add on therapy…
CTRI/2020/08/027428 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/08/027428 |
|---|---|
| Public title | A phase-III clinical trial to study the effects of vitamin D3 add on therapy with escitalopram in depression. |
| Scientific title | Randomized, double-blind, placebo-controlled trial on the impact of vitamin D supplementation on treatment and outcome of depression |
| Primary sponsor | Dr P N Suresh Kumar |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: F321- Major depressive disorder, singleepisode, moderate |
| Interventions | Intervention1: vitamin D: Oral vitamin D capsule (50,000 IU every 5 days for 12 weeks Control Intervention1: Placebo: Identical oral dummy placebo capsule once in 5 days for 12 weeks |
| Registration date | Aug 27, 2020 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: